NCT05630118 is a NA clinical trial of SHUTi Intervention in Alcohol Use Disorder, sponsored by Jessica Weafer.

Who is sponsoring NCT05630118?

NCT05630118 is sponsored by Jessica Weafer.

What drugs are being tested in NCT05630118?

Interventions in NCT05630118: SHUTi Intervention, Web-Based Insomnia Education Program.

What condition does NCT05630118 study?

NCT05630118 studies Alcohol Use Disorder, Heavy Drinking.

Is NCT05630118 still recruiting?

NCT05630118 is currently completed. Last updated 5 February 2026.

Last reviewed 2026-02-05 · How we verify

NCT05630118

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Online Insomnia Intervention to Reduce Alcohol Use

Completed NA Last updated 5 February 2026

What this trial tests

NA trial testing SHUTi Intervention in Alcohol Use Disorder in 113 participants. Completed in 7 July 2025.

Timeline

24 January 2023

Primary endpoint
7 July 2025

7 July 2025

Quick facts

Lead sponsor	Jessica Weafer
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	113
Start date	24 January 2023
Primary completion	7 July 2025
Estimated completion	7 July 2025
Sites	1 location across United States

Drugs / interventions tested

SHUTi Intervention
Web-Based Insomnia Education Program

Conditions studied

Alcohol Use Disorder — all drugs for Alcohol Use Disorder →
Heavy Drinking — all drugs for Heavy Drinking →

Sponsor

Jessica Weafer

Who can join

Adults 18 to 50, any sex, with Alcohol Use Disorder or Heavy Drinking. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Alcohol use disorder (AUD) inflicts enormous physical, emotional, and financial burdens on the individual and society at large. Insomnia is highly prevalent among individuals with AUD, and disrupted sleep contributes substantially to alcohol-related problems. While research suggests that treating insomnia may effectively reduce AUD, the degree to which treating insomnia in heavy drinkers reduces alcohol consumption and prevents the onset of severe AUD is not known. This study will be the first to evaluate an Internet-based version of cognitive behavioral therapy for insomnia (CBT-I) in community-dwelling, heavy drinking adults with insomnia. Sleep Healthy Using the Internet (SHUTi), the most widely-used and well-validated version of Internet-based CBT-I will be used. The primary aim is to reduce alcohol consumption and insomnia severity in this population.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of digital cognitive-behavioral therapy for insomnia in heavy drinkers with insomnia: A replication and extension study.
Verlinden JJ, Moloney ME, Vsevolozhskaya OA, Ritterband LM, et al · · 2026 · PMID 41785115 · DOI 10.1037/pha0000834

Verify or expand the search:

Other trials of SHUTi Intervention

Trials testing the same drug.

NCT04564807 — Testing an Online Insomnia Intervention · NA · completed

Other recruiting trials for Alcohol Use Disorder

Currently open trials in the same condition.

NCT06860607 — Environment and Alcohol: A Pilot Study · Phase 1 · recruiting
NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
NCT07046819 — Tirzepatide in MetALD · Phase 2 · recruiting
NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
NCT07056894 — Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis · NA · recruiting

Other Jessica Weafer trials

Trials by the same sponsor.

NCT05929677 — Impulsivity Domains and Subjective Response · EARLY_PHASE1 · recruiting
NCT04929288 — Neural and Hormonal Influences on Sex Differences in Risk for AUD · NA · recruiting
NCT04564807 — Testing an Online Insomnia Intervention · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05630118 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jessica Weafer
Last refreshed: 5 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05630118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing